Live Breaking News & Updates on Diagnostic Segment

Stay updated with breaking news from Diagnostic segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kepler Capital Sticks to Their Buy Rating for Grifols SA (GRFS)

In a report released on July 27, Pablo de Renteria from Kepler Capital maintained a Buy rating on Grifols SA (GRFS – Research Report), wi. ....

Comunidad Autonoma De Cataluna , Antonio Grifols Roig , Pablo De Renteria , Kepler Capital , Research Report , Moderate Buy , Bio Supplies , Bioscience Segment , Hospital Segment , Diagnostic Segment ,

Stevanato Group S.p.A.: Stevanato Group Announces Second Quarter 2021 Financial Results

- Establishes Full Year 2021 Guidance - Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology ....

United States , Franco Moro , Franco Stevanato , Italian Tax Agency , York Stock Exchange , Company Investor Relations , Exchange Commission , Development Expenses , Stevanato Group , New York Stock Exchange , Company Quarterly Report On Form , Full Year , Chief Executive Officer , Executive Chairman , Diagnostic Segment , Engineering Segment , Financial Information , Investor Relations , Quarterly Report , Securities Act , Marketing Expenses , Administrative Expenses , Diagnostic Solutions , Constant Currency Revenue , Adjusted Operating Profit , Adjusted Operating Profit Margin ,